Tumor Microenvironment Responsive Nanomicelle with Folic Acid Modification Co-Delivery of Doxorubicin/Shikonin for Triple Negative Breast Cancer Treatment

Triple negative breast cancer (TNBC), which has poor prognosis, easily develops drug resistance and metastasizes. In general, those TNBC characteristics are related to a high activation of the epithelial-mesenchymal transition (EMT) pathway, which is inhibited by shikonin (SKN). Therefore, the syner...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Wu, Shen, Zhehao, Wang, Menglan, Wang, Hongyi, Sun, Yuting, Tao, Xiaojun, Hou, Defu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055947/
https://www.ncbi.nlm.nih.gov/pubmed/36986473
http://dx.doi.org/10.3390/ph16030374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055947/
https://www.ncbi.nlm.nih.gov/pubmed/36986473
http://dx.doi.org/10.3390/ph16030374

Ejemplares similares